These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1622184)

  • 1. Distribution of ciprofloxacin in ascitic fluid following administration of a single oral dose of 750 milligrams.
    Dan M; Zuabi T; Quassem C; Rotmensch HH
    Antimicrob Agents Chemother; 1992 Mar; 36(3):677-8. PubMed ID: 1622184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ciprofloxacin into human peritoneal tissue following a single oral dose of 750 milligrams.
    Dan M; Serour F; Poch F
    J Chemother; 1992 Feb; 4(1):27-9. PubMed ID: 1403066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
    Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
    Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
    Catchpole C; Andrews JM; Woodcock J; Wise R
    J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
    Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
    Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffusion of cefotiam into ascitic fluid].
    Dao C; Hercelin B; Chotard Y; Veil N
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):527-9. PubMed ID: 3911148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid.
    Sambatakou H; Giamarellos-Bourboulis EJ; Galanakis N; Giamarellou H
    Int J Antimicrob Agents; 2001 Nov; 18(5):441-4. PubMed ID: 11711259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
    Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis.
    Mikamo H; Ninomiya M; Tamaya T
    J Infect Chemother; 2003 Sep; 9(3):276-7. PubMed ID: 14513401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.
    Healy DP; Brodbeck MC; Clendening CE
    Antimicrob Agents Chemother; 1996 Jan; 40(1):6-10. PubMed ID: 8787869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Hauptman JG; MacDonald KH; Budsberg SC; Rosser EJ
    Am J Vet Res; 1990 Jun; 51(6):896-900. PubMed ID: 2195927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
    Cardey J; Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Fourtillan JP; Beauchant M
    Eur J Clin Pharmacol; 1987; 33(5):469-72. PubMed ID: 3480805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
    Fabre D; Bressolle F; Gomeni R; Arich C; Lemesle F; Beziau H; Galtier M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2521-5. PubMed ID: 1810184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis.
    Runyon BA; Akriviadis EA; Sattler FR; Cohen J
    Dig Dis Sci; 1991 Dec; 36(12):1782-6. PubMed ID: 1748049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
    Garraffo R; Dellamonica P; Bernard E; Etesse H; Lapalus P
    Int J Clin Pharmacol Res; 1989; 9(1):29-35. PubMed ID: 2707923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data.
    Jehl F; Adloff M; Monteil H; Brogard JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):115-22. PubMed ID: 3691576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
    Panneton AC; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
    Frost RW; Lettieri JT; Krol G; Shamblen EC; Lasseter KC
    Clin Pharmacol Ther; 1989 Jun; 45(6):608-16. PubMed ID: 2731404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.